alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,901–5,925 of 7,816 matching trials · page 237 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging
NCT02844478
SBP English; SBP SPANISH
Runs in: United States · 1 site 		NA
other		 COMPLETED 37 The University of Texas Health Science Center at San Antonio
OTHER		 2018-10-16
Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
NCT03030105
BPN14770; BPN14770 placebo; Donepezil; Donepezil placebo; Scopolami...
Runs in: United States · 1 site 		PHASE1
symptomatic-cholinergic		 COMPLETED 38 Tetra Discovery Partners
INDUSTRY		 2018-10-16
Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics
NCT03641768
MRI; PET; 18F-Florbetapir; Radioligand 18F-AV-1451
Runs in: United States · 1 site 		NA
other		 WITHDRAWN 0 Duke University
OTHER		 2018-10-16
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
NCT02317250
Amyloid imaging; FDG-PET 		PHASE3
other		 WITHDRAWN 0 University of California, Los Angeles
OTHER		 2018-10-15
Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
NCT01318408
Levetiracetam
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 24 Drexel University College of Medicine
OTHER		 2018-10-12
Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)
NCT02064920
Placebo; Donepezil; Donepezil 		PHASE2
symptomatic-cholinergic		 COMPLETED 36 Merck Sharp & Dohme LLC
INDUSTRY		 2018-10-12
New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders)
NCT02462291
Ecological Environmental therapy
Runs in: Italy · 1 site 		NA
other		 COMPLETED 163 Universita di Verona
OTHER		 2018-10-12
The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment
NCT02590874
Duloxetine; Placebo
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 19 University of North Texas Health Science Center
OTHER		 2018-10-11
Fall Prevention - Vestibular Rehabilitation
NCT03221296
Vestibular Training (Intervention Group)
Runs in: Canada · 1 site 		NA
other		 COMPLETED 29 University Health Network, Toronto
OTHER		 2018-10-11
Pilot Study of the Effects of Playing Golf on People With Dementia
NCT03462485
Golf
Runs in: United Kingdom · 1 site 		NA
other		 UNKNOWN 24 University of Bedfordshire
OTHER		 2018-10-11
Are Cognition and Sleep Affected by Exposure to Carbon Dioxide and Bio Effluents During Sleep?
NCT03558698
Good ventilation; Ventilation CO2; Poor Ventilation
Runs in: Denmark · 1 site 		NA
other		 COMPLETED 36 University of Aarhus
OTHER		 2018-10-11
Managing Vascular Dementia Risk Factors With SymTrend
NCT03702543
SymTrend, Inc.
Runs in: United States · 1 site 		PHASE1
other		 UNKNOWN 10 SymTrend Inc.
INDUSTRY		 2018-10-11
Nicotine Replacement Therapy in the Intensive Care Unit
NCT01362959
Transdermal nicotine patch; Cutaneous patch, containing no active s...
Runs in: Netherlands · 2 sites 		PHASE4
other		 COMPLETED 47 Gelderse Vallei Hospital
OTHER		 2018-10-10
An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease
NCT02293915
Sodium oligo-mannurarate 900mg; Placebo
Runs in: China · 16 sites 		PHASE3
other		 COMPLETED 818 Shanghai Greenvalley Pharmaceutical Co., Ltd.
INDUSTRY		 2018-10-10
Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease
NCT02709356
1-month of 60-40 MCT oil; 1-month of C8 MCT oil
Runs in: Canada · 1 site 		NA
other		 COMPLETED 20 Université de Sherbrooke
OTHER		 2018-10-10
Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression
NCT02303158
Runs in: Spain · 1 site 		NA
other		 TERMINATED 50 Institut Investigacio Sanitaria Pere Virgili
OTHER		 2018-10-09
Evaluating a Digital Memory Notebook App to Improve Functional Independence
NCT03453554
Digital Notebook app; Smart Home Prompting
Runs in: United States · 1 site 		NA
other		 UNKNOWN 30 Washington State University
OTHER		 2018-10-09
Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101
NCT03624322
Zyprexa IM; Zydis; INP105; I231 POD® Device
Runs in: Australia · 1 site 		PHASE1
other		 COMPLETED 38 Impel Pharmaceuticals
INDUSTRY		 2018-10-04
ESCAPE Study : Validation of a Specific Tool Scoring Residents at Risk of Escaping/Elopement From Nursing Homes (ESCAPE)
NCT03662464
No intervention
Runs in: France · 1 site 		NA
other		 UNKNOWN 4,050 Assistance Publique Hopitaux De Marseille
OTHER		 2018-10-04
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
NCT00946530
Bright light; Control
Runs in: United States · 1 site 		NA
other		 COMPLETED 118 Stanford University
OTHER		 2018-10-03
Intervention Based on Implicit Theories of Personality: Effects on Depression and Bullying
NCT03481699
Incremental theory of personality; Educational Intervention 		NA
other		 COMPLETED 882 University of Deusto
OTHER		 2018-10-03
Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients
NCT03630419
Mito-Food Plan; Cellular Repair Therapy
Runs in: United States · 1 site 		PHASE1|PHASE2
other		 COMPLETED 5 Perseverance Research Center, LLC
OTHER		 2018-10-02
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
NCT02910739
MK-8931 		PHASE1
other		 COMPLETED 16 Merck Sharp & Dohme LLC
INDUSTRY		 2018-10-01
Feasibility and Efficacy of the Ketogenic Diet in Alzheimer's Disease
NCT03690193
Ketogenic Diet 		NA
other		 COMPLETED 15 University of Kansas Medical Center
OTHER		 2018-10-01
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
NCT00571064
Donepezil HCl
Runs in: United States · 36 sites 		PHASE4
symptomatic-cholinergic		 COMPLETED 97 Eisai Inc.
INDUSTRY		 2018-09-27

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →